Xeris Biopharma Holdings, Inc. (XERS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 03:01PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 260.19M |
| Enterprise Value | 416.93M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.47 |
| Price/Book (mrq) | 3.86 |
| Enterprise Value/Revenue | 2.54 |
| Enterprise Value/EBITDA | -17.57 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.11 |
| 52-Week Change 3 | -24.24% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 3.2600 |
| 52 Week Low 3 | 1.4600 |
| 50-Day Moving Average 3 | 2.2276 |
| 200-Day Moving Average 3 | 2.1847 |
Share Statistics
| Avg Vol (3 month) 3 | 1.88M |
| Avg Vol (10 day) 3 | 1.13M |
| Shares Outstanding 5 | 148.25M |
| Implied Shares Outstanding 6 | 148.25M |
| Float 8 | 136.52M |
| % Held by Insiders 1 | 3.74% |
| % Held by Institutions 1 | 41.72% |
| Shares Short (Apr 15, 2024) 4 | 8.94M |
| Short Ratio (Apr 15, 2024) 4 | 5.86 |
| Short % of Float (Apr 15, 2024) 4 | 6.18% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 6.03% |
| Shares Short (prior month Mar 15, 2024) 4 | 9.24M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -37.98% |
| Operating Margin (ttm) | -22.17% |
Management Effectiveness
| Return on Assets (ttm) | -8.25% |
| Return on Equity (ttm) | -324.20% |
Income Statement
| Revenue (ttm) | 163.91M |
| Revenue Per Share (ttm) | 1.19 |
| Quarterly Revenue Growth (yoy) | 33.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -31.68M |
| Net Income Avi to Common (ttm) | -62.26M |
| Diluted EPS (ttm) | -0.4500 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 72.45M |
| Total Cash Per Share (mrq) | 0.52 |
| Total Debt (mrq) | 229.19M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.64 |
| Book Value Per Share (mrq) | -0.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -47.02M |
| Levered Free Cash Flow (ttm) | -19.62M |
© 2024 Yahoo. All rights reserved.